Guihot A - Search Results

1

Performance of Quantiferon(®) for the diagnosis TB.

Meyssonnier V, Guihot A, Chevet K, Veziris N, Assoumou L, Bourgarit A, Costagliola D, Caumes E, Carcelin G. Meyssonnier V, et al. Among authors: guihot a. Med Mal Infect. 2012 Dec;42(12):579-84. doi: 10.1016/j.medmal.2012.08.003. Epub 2012 Nov 7. Med Mal Infect. 2012. PMID: 23141871 Clinical Trial.

2

T-SPOT.TB performed in lymphnodal tissue for the diagnosis of lymphadenitic TB.

Tunesi S, Salah EB, Taybaly M, Litvinova E, Sellier N, Guihot A, Bourgarit A. Tunesi S, et al. Among authors: guihot a. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):688-690. doi: 10.5588/ijtld.22.0055. Int J Tuberc Lung Dis. 2022. PMID: 35768911 No abstract available.

3

[Etiology of ecthyma gangrenosum: four cases].

Soria A, Francès C, Guihot A, Varnous S, Bricaire F, Caumes E. Soria A, et al. Among authors: guihot a. Ann Dermatol Venereol. 2010 Jun-Jul;137(6-7):472-6. doi: 10.1016/j.annder.2010.04.013. Epub 2010 Jun 11. Ann Dermatol Venereol. 2010. PMID: 20620579 French.

4

Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus.

Guihot A, Bourgarit A, Carcelain G, Autran B. Guihot A, et al. Trends Immunol. 2011 Mar;32(3):131-7. doi: 10.1016/j.it.2010.12.002. Epub 2011 Feb 12. Trends Immunol. 2011. PMID: 21317040 Review.

5

[Observational study of QuantiFERON® management for ocular tuberculosis diagnosis: Analysis of 244 consecutive tests].

Amara A, Ben Salah E, Guihot A, Fardeau C, Touitoue V, Saadoun D, Bodaghi B, Sève P, Trad S. Amara A, et al. Among authors: guihot a. Rev Med Interne. 2021 Mar;42(3):162-169. doi: 10.1016/j.revmed.2020.09.005. Epub 2020 Nov 2. Rev Med Interne. 2021. PMID: 33143863 French.

6

Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.

Hattab S, Guiguet M, Carcelain G, Fourati S, Guihot A, Autran B, Caby F, Marcelin AG, Costagliola D, Katlama C. Hattab S, et al. Among authors: guihot a. HIV Med. 2015 Oct;16(9):553-62. doi: 10.1111/hiv.12257. Epub 2015 May 6. HIV Med. 2015. PMID: 25944318 Free article.

7

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia.

Guihot A, Dentone C, Assoumou L, Parizot C, Calin R, Seang S, Soulié C, Marcelin AG, Calvez V, Autran B, Katlama C, Costagliola D, Carcelain G. Guihot A, et al. AIDS. 2016 Jan;30(2):327-30. doi: 10.1097/QAD.0000000000000815. AIDS. 2016. PMID: 26186129

8

Management of travelers with fever and exanthema, notably dengue and chikungunya infections.

Hochedez P, Canestri A, Guihot A, Brichler S, Bricaire F, Caumes E. Hochedez P, et al. Among authors: guihot a. Am J Trop Med Hyg. 2008 May;78(5):710-3. Am J Trop Med Hyg. 2008. PMID: 18458301

9

Clinical management of rapidly growing mycobacterial cutaneous infections in patients after mesotherapy.

Regnier S, Cambau E, Meningaud JP, Guihot A, Deforges L, Carbonne A, Bricaire F, Caumes E. Regnier S, et al. Among authors: guihot a. Clin Infect Dis. 2009 Nov 1;49(9):1358-64. doi: 10.1086/606050. Clin Infect Dis. 2009. PMID: 19814609

10

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.

Guihot A, Tubiana R, Breton G, Marcelin AG, Samri A, Assoumou L, Goncalves E, Bricaire F, Costagliola D, Calvez V, Rouzioux C, Autran B, Katlama C, Carcelain G; ALT-ANRS CO-15 study group; DECAMUNE study group. Guihot A, et al. AIDS. 2010 Feb 20;24(4):614-7. doi: 10.1097/QAD.0b013e32833556f3. AIDS. 2010. PMID: 19952710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters